Home › Alzheimer's Disease › New Jersey › Clifton
Alzheimer's Disease clinical trials in Clifton, NJ
4 studies for Alzheimer's Disease are looking for participants at sites in and around Clifton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons
Recruiting
- Kessler Foundation, East Hanover · 11 mi away
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
Recruiting
- Hackensack Medical Center, Hackensack · 7 mi away
A Postmarketing Study of Lecanemab for the Treatment of Participants With Alzheimer's Disease
RecruitingObservational study
- Eisai Trial Site #1, Nutley · 3 mi away
A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease
RecruitingObservational study
- Eisai Trial Site #1, Nutley · 3 mi away
About Alzheimer's Disease
Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.
More about Alzheimer's Disease on MedlinePlus
Alzheimer's Disease trials in other cities
- Boston, MA26 studies
- Orlando, FL25 studies
- St. Louis, MO22 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Tampa, FL17 studies
- Atlanta, GA16 studies
- Philadelphia, PA15 studies
- The Villages, FL15 studies
- Phoenix, AZ15 studies
- Indianapolis, IN14 studies
- Los Angeles, CA14 studies
Other studies in Clifton
- Non-Small Cell Lung Cancer24 studies
- Cancer (all types)15 studies
- Multiple Myeloma14 studies
- Metastatic Cancer12 studies
- Acute Myeloid Leukemia12 studies
- Breast Cancer12 studies
- Prostate Cancer12 studies
- Ovarian Cancer11 studies
- Lung Cancer10 studies
- Colorectal Cancer8 studies
- Head and Neck Squamous Cell Carcinoma8 studies
- Endometrial Cancer8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.